OA08215A - Molécule comportant au moins une séquence peptidique porteuse d'un épitope caractéristique d'une protéine produite par des cellules infectées par les parasites du paludisme et compositions les contenant. - Google Patents

Molécule comportant au moins une séquence peptidique porteuse d'un épitope caractéristique d'une protéine produite par des cellules infectées par les parasites du paludisme et compositions les contenant.

Info

Publication number
OA08215A
OA08215A OA58798A OA58798A OA08215A OA 08215 A OA08215 A OA 08215A OA 58798 A OA58798 A OA 58798A OA 58798 A OA58798 A OA 58798A OA 08215 A OA08215 A OA 08215A
Authority
OA
OAPI
Prior art keywords
molecule
compositions containing
peptide sequence
cells infected
protein produced
Prior art date
Application number
OA58798A
Other languages
English (en)
French (fr)
Inventor
Michael Koenen
Arthur Scherf
Benno Muller-Hill
Odile Mercereau-Puijalon
Da Silva Luiz Pereira
Original Assignee
Inst Pasteur & Centre National
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Pasteur & Centre National filed Critical Inst Pasteur & Centre National
Publication of OA08215A publication Critical patent/OA08215A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
OA58798A 1984-07-02 1986-02-28 Molécule comportant au moins une séquence peptidique porteuse d'un épitope caractéristique d'une protéine produite par des cellules infectées par les parasites du paludisme et compositions les contenant. OA08215A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8410461A FR2566780B1 (fr) 1984-07-02 1984-07-02 Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant

Publications (1)

Publication Number Publication Date
OA08215A true OA08215A (fr) 1987-10-30

Family

ID=9305696

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58798A OA08215A (fr) 1984-07-02 1986-02-28 Molécule comportant au moins une séquence peptidique porteuse d'un épitope caractéristique d'une protéine produite par des cellules infectées par les parasites du paludisme et compositions les contenant.

Country Status (7)

Country Link
EP (1) EP0191028B1 (de)
AU (1) AU599004B2 (de)
CA (1) CA1268600A (de)
DE (1) DE3571442D1 (de)
FR (1) FR2566780B1 (de)
OA (1) OA08215A (de)
WO (1) WO1986000620A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
AU2442792A (en) * 1991-07-31 1993-03-02 Institut Pasteur Polypeptides capable of (in vivo) induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of (p.falciparum), related products and their use in producing vaccine compositions
AU3423293A (en) * 1991-12-19 1993-07-19 Baylor College Of Medicine Pva or peg conjugates of peptides for epitope-specific immunosuppression
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays
EP1544211A1 (de) 2003-12-15 2005-06-22 Institut Pasteur Pre-erythrozytäres LSA-5 Antigen von Plasmodium falciparum, Impfstoff gegen Malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein

Also Published As

Publication number Publication date
DE3571442D1 (en) 1989-08-17
FR2566780B1 (fr) 1987-02-06
FR2566780A1 (fr) 1986-01-03
AU599004B2 (en) 1990-07-12
WO1986000620A1 (fr) 1986-01-30
AU4543185A (en) 1986-02-10
CA1268600A (fr) 1990-05-01
EP0191028B1 (de) 1989-07-12
EP0191028A1 (de) 1986-08-20

Similar Documents

Publication Publication Date Title
UA40572C2 (uk) Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
IT1174205B (it) Fluoroplieteri contenenti gruppi terminali dotati di proprieta' ancoranti
DE3586313D1 (de) Konjugate von pharmazeutisch nuetzlichen proteinen.
FR2679230B1 (fr) Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
IT1232848B (it) Composizione di sciampo limpido
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2595120B1 (fr) Tubulure de raccord entre carburateur et chambre d'explosion
IT8522265A0 (it) Capacita' di rivelazione dinodo di commutazione di pacchetti guasti. ad autoinstradamento alterno avente
OA08278A (fr) Glycoprototéine d'enveloppe du LAV II .
IT8347558A0 (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
FR2596651B1 (fr) Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
OA08215A (fr) Molécule comportant au moins une séquence peptidique porteuse d'un épitope caractéristique d'une protéine produite par des cellules infectées par les parasites du paludisme et compositions les contenant.
OA07800A (fr) Faction polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogènes les contenant.
DE3880699D1 (de) Thyristor vom nulldurchgangstyp.
IT1164862B (it) Polipeptide dotato di attivita' di interferon, composizione che lo contiene e procedimento di preparazione
ES539738A0 (es) Un procedimiento de preparar una composicion quimica, marca-dora de material proteinico
BR8506691A (pt) Composicoes de peneira molecular de oxido de titanio aluminio-silicio
IT8347559A0 (it) Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione
IT8522730A0 (it) Ferro-derivati della globina e dell'acetilglobina dotati di elevata biodisponibilita', processo di preparazione e composizioni farmaceutiche.
IT1203903B (it) Pupazzo perfezionato con un meccanismo di voce combinato con l'azionamento della bocca e degli occhi
FR2562766B1 (fr) Compositions repulsives contre les insectes, les tiques et les acariens contenant au moins un n-phenylthiocarbamate de o-alkyle et du n,n-diethyl-m-toluamide
DE3751379D1 (de) Elektrode und Drahtmaterial aus Wolfram von zweifältiger Zusammensetzung.
IT8683611A0 (it) Struttura npn equivalente con tensione di rottura maggiorata rispetto alla tensione di rottura intrinseca dell'npn.
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
EP0502553A3 (en) Peptide fragment from human villin and antibody thereto